Related Experiment Videos

The management of perforated gastric ulcers

Matthew Fraser Leeman1, Christos Skouras, Simon Paterson-Brown

  • 1Department of Surgery, Royal Infirmary of Edinburgh, 51 Little France Crescent, Old Dalkeith Road, Edinburgh, United Kingdom. mfleeman@nhs.net

Insights

Emergency laparotomy for perforated gastric ulcers, primarily managed with omental patch repair, shows effective outcomes. Careful biopsy and follow-up endoscopy are crucial for detecting underlying gastric cancer.

Area of Science:

  • Gastroenterology
  • Surgical Emergency Management
  • Oncology

Background:

  • Perforated gastric ulcers represent a significant surgical emergency requiring prompt management to prevent complications like gastrectomy.
  • Early intervention is critical for favorable patient outcomes.

Purpose of the Study:

  • To evaluate the management strategies and outcomes for patients with gastric ulcer perforation undergoing emergency laparotomy.
  • To assess the effectiveness of different surgical approaches and identify factors influencing patient outcomes.

Main Methods:

  • Retrospective analysis of 44 patients with perforated gastric ulcers undergoing emergency laparotomy between 2007-2011.
  • Data collected from the Lothian Surgical Audit database, electronic records, and case notes.
  • Surgical procedures included omental patch repair, simple closure, and distal gastrectomy.

Main Results:

  • Omental patch repair was the predominant procedure (91%).
  • Four cases (8.8%) of perforated gastric tumors were identified, managed conservatively initially.
  • The overall in-hospital mortality rate was 15.9%, with a morbidity rate of 54.5%.

Conclusions:

  • Laparotomy with omental patch repair is an effective management for most perforated gastric ulcers.
  • Routine biopsy and follow-up endoscopy are essential for diagnosing underlying gastric malignancy.
Abstract

Related Concept Videos

Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...